This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Common semaglutide side effects include nausea, vomiting, ...

We may have a new champion when it comes to pills that can manage both blood sugar levels and weight loss. In a phase 3 ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

A secondary analysis of the SOUL trial shows significant improvement in heart failure outcomes with oral semaglutide vs placebo, consistent with the injectable formulation.

ACHIEVE-3 randomized 1698 metformin-treated adults with inadequately controlled type 2 diabetes to once-daily orforglipron ...

Chennai, March 5 -- Highlights: ...

A clinical trial for diabetes that pit orforglipron, a diabetes and weight-loss pill developed by Eli Lilly, against oral ...

BURLINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches for the treatment of ...

Once-daily orforglipron induced greater reductions in HbA1c and body weight than once-daily oral semaglutide for adults with type 2 diabetes, according to data from the ACHIEVE-3 trial published in ...

By Mariam Sunny March 3 (Reuters) - Strive Pharmacy said on Tuesday it has no plans to resume sales of a compounded version of Novo Nordisk's oral semaglutide, pushing back on an earlier media report ...

Talk about semaglutide—the drug better known by brand names like Ozempic, Wegovy, and Rybelsus—is everywhere these days. But if you’re considering getting pregnant or want to use the med ...